Laxatives for the management of constipation in people receiving palliative care
- 13 May 2015
- journal article
- review article
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2020 (1) , CD003448
Abstract
Background This article describes the second update of a Cochrane review on the effectiveness of laxatives for the management of constipation in people receiving palliative care. Previous versions were published in 2006 and 2010 where we also evaluated trials of methylnaltrexone; these trials have been removed as they are included in another review in press. In these earlier versions, we drew no conclusions on individual effectiveness of different laxatives because of the limited number of evaluations. This is despite constipation being common in palliative care, generating considerable suffering due to the unpleasant physical symptoms and the availability of a wide range of laxatives with known differences in effect in other populations. Objectives To determine the effectiveness and differential efficacy of laxatives used to manage constipation in people receiving palliative care. Search methods We searched the Cochrane Central Register of Controlled Trials (CENTRAL; The Cochrane Library), MEDLINE, EMBASE, CINAHL and Web of Science (SCI & CPCI‐S) for trials to September 2014. Selection criteria Randomised controlled trials (RCTs) evaluating laxatives for constipation in people receiving palliative care. Data collection and analysis Two authors assessed trial quality and extracted data. The appropriateness of combining data from the studies depended upon clinical and outcome measure homogeneity. Main results We identified five studies involving the laxatives lactulose, senna, co‐danthramer, misrakasneham, docusate and magnesium hydroxide with liquid paraffin. Overall, the study findings were at an unclear risk of bias. As all five studies compared different laxatives or combinations of laxatives, it was not possible to perform a meta‐analysis. There was no evidence on whether individual laxatives were more effective than others or caused fewer adverse effects. Authors' conclusions This second update found that laxatives were of similar effectiveness but the evidence remains limited due to insufficient data from a few small RCTs. None of the studies evaluated polyethylene glycol or any intervention given rectally. There is a need for more trials to evaluate the effectiveness of laxatives in palliative care populations. Extrapolating findings on the effectiveness of laxatives evaluated in other populations should proceed with caution. This is because of the differences inherent in people receiving palliative care that may impact, in a likely negative way, on the effect of a laxative.Keywords
This publication has 43 references indexed in Scilit:
- Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPCThe Lancet Oncology, 2012
- Clinical use of oral laxatives in palliative care services in SpainSupportive Care in Cancer, 2010
- Lactulose versus Polyethylene Glycol for Chronic ConstipationCochrane Database of Systematic Reviews, 2010
- Patient assessment of a novel therapeutic approach for the treatment of severe, chronic painInternational Journal Of Clinical Practice, 2008
- Grading quality of evidence and strength of recommendations for diagnostic tests and strategiesBMJ, 2008
- Managing Morphine-Induced ConstipationJournal of Pain and Symptom Management, 1998
- Efficacy of senna versus lactulose in terminal cancer patients treated with opioidsJournal of Pain and Symptom Management, 1998
- Stool Form Scale as a Useful Guide to Intestinal Transit TimeScandinavian Journal of Gastroenterology, 1997
- A clinical comparison of laxatives in a hospicePalliative Medicine, 1991
- A study of the relative frequency and importance of gastrointestinal symptoms, and weakness in patients with far advanced cancer: student paperPalliative Medicine, 1990